HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical spectrum of restrictive cardiomyopathy in children.

Abstract
We reviewed the clinical spectrum and possible prognostic factors in 14 children with restrictive cardiomyopathy. The patients were not homogeneous in clinical presentation or morphology. The mortality rate was high: 21.4% at 1 year and 50% at 2 years after presentation. Younger patients with respiratory symptoms, thromboembolism, increased cardiothoracic ratio on chest radiogram or patients with endocardial fibroelastosis appear to have a worse prognosis and orthotopic cardiac transplantation may be indicated.
AuthorsS C Chen, I C Balfour, S Jureidini
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (J Heart Lung Transplant) Vol. 20 Issue 1 Pg. 90-2 (Jan 2001) ISSN: 1053-2498 [Print] United States
PMID11166616 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Diuretics
  • Vasodilator Agents
Topics
  • Adolescent
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Biopsy
  • Cardiac Catheterization
  • Cardiomyopathy, Restrictive (diagnosis, mortality, physiopathology, therapy)
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Disease Progression
  • Diuretics (therapeutic use)
  • Drug Therapy, Combination
  • Echocardiography, Doppler
  • Electrocardiography
  • Female
  • Heart Transplantation
  • Humans
  • Infant
  • Male
  • Myocardial Contraction
  • Prognosis
  • Radiography, Thoracic
  • Retrospective Studies
  • Severity of Illness Index
  • Survival Rate
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: